EXPONENT INC is 1.3x more valuable than Astrana Health, Inc. by market capitalization ($2.74 B vs $2.16 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | EXPO | ASTH |
|---|---|---|
| Market cap | $2.74 B | $2.16 B |
| US-listed rank | #1894 | #2049 |
| Revenue (latest FY) | $582.01M | $3.18B |
| Net income (latest FY) | $106.01M | $24.00M |
| Net margin | 18.2% | 0.8% |
| P/E (trailing FY) | 25.8 | 89.9 |
| SEC filings | 2,029 | 1,003 |
EXPONENT INC is 1.3x more valuable than Astrana Health, Inc. by market capitalization ($2.74 B vs $2.16 B).
In their latest fiscal years, EXPONENT INC reported $582.01M in revenue while Astrana Health, Inc. reported $3.18B.
Full pages: EXPONENT INC and Astrana Health, Inc., or browse the full rankings.